BLBD - Blue Bird Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$89.00
DETAILS
HIGH:
$95.00
LOW:
$85.00
MEDIAN:
$86.00
CONSENSUS:
$89.00
UPSIDE:
46.99%
AlphaVal
Deterministic, archetype-aware fair value
Cyclical & Capital-Intensive
80% confidence
Primary model: Normalized Earnings × Cycle Multiple
Adjust Assumptions
9.5x
1.02$
Key Value Driver
Through-cycle normalized EPS ($1.02)
Implied Market Multiple
59.4x
Plain-Language Summary
Using 7-year normalized EPS of $1.02 at a 10x cycle multiple, the base-case value is $9.69 per share. P/TBV cross-check: 9.8x.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (12 analysts)
$89.00
Analyst Range
$85.00 – $95.00
Divergence from AlphaVal
89%
Warnings
Recent profits ($3.88/share) are 280% above the mid-cycle average ($1.02). Buying based on peak profits is the most common mistake with boom-and-bust businesses.
Price-to-book value of 9.8x is above the normal range for this type of business (0.7x-2.0x). The stock may already price in a strong cycle.
Wall Street's average price target is $89.00 (from 12 analysts). Our estimate is 89% below the consensus -- consider that gap carefully.
Key Risks
- Standard 10-year DCF produces unreliable terminal values for cyclicals
- 'Cheap' P/E at cycle peak is the most common value trap — normalize first
- Captive finance subsidiaries have different risk profiles from manufacturing